You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
First multi-year cumulation covers six years: 1965-70.
This monograph provides a comprehensive review of the poxvirus family with a particular emphasis on current developments. It includes the latest insights into poxviral molecular biology, diagnosis, therapy, vaccine development and the beneficial exploitation of these viruses in biomedical research. Each chapter is written by a leader in the field, and the book includes historical perspectives and summaries of recent advances in the field.
This report presents the recommendations of a WHO Expert Committee commissioned to coordinate activities leading to the adoption of international recommendations for the production and control of vaccines and other biological substances, and the establishment of international biological reference materials. Following a brief introduction, the report summarizes a number of general issues brought to the attention of the Committee. The next part of the report, of particular relevance to manufacturers and national regulatory authorities, outlines the discussions held on the development and adoption of new and revised WHO Recommendations, Guidelines and guidance documents. Following these discuss...
The Nescience of Medicine Includes - COVID-19 THE UN-TOLD STORY Part 2 Provides a Detailed Explanation of the Covid-19 Fraud An inside account of the events Before, During and After! CONTENTS Preface.........................................................................................1 Advice to the Medical Trade.......................................................2 We Have Been Here Before........................................................3 Chapter 1 Science and Nescience................................................................4 Covid-19 The UN-Told Story Part 2...........................................7 Dis-information Mis-information Mal-information & The Medical Trade.....
Using the published work of Nobel Laureate Niels Kaj Jerne, this book shows how he developd his ideas. The book is a compilation of his published work, but in fact it is much more than that. Whether the reader wants to read the book systematically, or only browse, it opens a fascinating world of hypotheses, theories, facts and vistas. His selection theory, his view of how immunological diversity is created, and his concept of lymphocytes interacting as a network, reveals Jerne's revolutionary spirit. The book ought to be a rich source of inspiration for everyone interested in science and how science is made.
The seventy-second meeting of the WHO Expert Committee on Biological Standardization was held from 19 to 23 October 2020 by WebEx video conferencing due to the restrictions imposed during the coronavirus disease 2019 (COVID-19) pandemic. The meeting was opened on behalf of the Director-General of WHO by Dr Mariângela Batista Galvão Simão, Assistant Director-General, Access to Medicines and Health Products. Dr Simão welcomed Committee members, meeting participants and observers. Dr Simão began by noting that the Committee had met as recently as August 2020, primarily to address standardization activities related to COVID-19, and that much remains to be learnt about the pandemic. The WHO Solidarity Trial was continuing to facilitate the rapid and robust comparison of potential treatments. Recently published interim results indicated that the four small molecule treatments remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon had little or no benefit in terms of overall mortality or speed of recovery of hospitalized patients – to date only dexamethasone had proved to be effective against severe COVID-19.
The purpose of this document is to provide technical guidance to in vitro diagnostic medical device (IVD) manufacturers that intend to seek WHO prequalification of rapid diagnostic tests (RDTs) for the detection of human immunodeficiency virus (HIV). The minimum performance requirements for WHO prequalification are summarized in this document, and apply equally to RDTs intended solely for HIV detection and those in which HIV detection is one component of a multi-detection assay (for example, an HIV/syphilis dual-detection RDT). This document applies to RDTs intended to be used as an aid to diagnosis of HIV infection. The current version of this document does not address IVDs that discriminate between the detection of HIV-1 and HIV-2 infection, IVDs intended as confirmatory tests, or the requirements for accompanying quality control materials.